Bumper Offer - Urjas oil Just @ Rs. 1
Rosuvas 5 Tablet (15), a prescription drug, is manufactured in various forms such as Tablet. High Cholesterol are some of its major therapeutic uses. The alternative uses of Rosuvas 5 Tablet (15) have also been explained below.
The correct dosage of Rosuvas 5 Tablet (15) depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Some other side effects of Rosuvas 5 Tablet (15) have been listed ahead. Usually, these side effects of Rosuvas 5 Tablet (15) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Rosuvas 5 Tablet (15)'s effect during pregnancy is Severe and Mild while nursing. Warnings related to Rosuvas 5 Tablet (15)'s effects on the liver, heart and kidney, if any, have been listed below.
Rosuvas 5 Tablet (15) is contraindicated in people with pre-existing medical conditions like Kidney Disease, Hypothyroidism, Drug Allergy as it can result in adverse effects. Other conditions have been mentioned below in the Rosuvas 5 Tablet (15) contraindications section.
Drug interactions for Rosuvas 5 Tablet (15) have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Rosuvas 5 Tablet (15) is considered safe while driving, and is addictive.
Rosuvas 5 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Rosuvas 5 Tablet (15) is used -
Severe
Moderate
Mild
Is the use of Rosuvas 5 Tablet (15) safe for pregnant women?
Rosuvas can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Rosuvas 5 Tablet (15) safe during breastfeeding?
Rosuvas may have very limited harmful effects for breastfeeding women.
What is the effect of Rosuvas 5 Tablet (15) on the Kidneys?
Rosuvas may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Rosuvas 5 Tablet (15) on the Liver?
Rosuvas may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Rosuvas 5 Tablet (15) on the Heart?
Rosuvas may have mild side effects on the heart. Most people will never see any effect on the heart.
Rosuvas 5 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Rosuvas 5 Tablet (15) unless your doctor advises you to do so -
Is this Rosuvas 5 Tablet (15) habit forming or addictive?
Forming a habit of Rosuvas 5 Tablet (15) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Rosuvas 5 Tablet (15) as it does not make you drowsy.
Is it safe?
Rosuvas 5 Tablet (15) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Rosuvas 5 Tablet (15) in mental disorders is not effective.
Interaction between Food and Rosuvas 5 Tablet (15)
Rosuvas 5 Tablet (15) may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Rosuvas 5 Tablet (15)
Consumption of alcohol and Rosuvas 5 Tablet (15) together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
